Royalty Transparency Act
This bill requires certain federal employees and members of specific health-related advisory committees (like those on vaccines or bioterrorism) to disclose royalties they receive from government-developed inventions. It mandates that agencies report the source and amount of these royalties online within 180 days, making this information publicly accessible. The law applies to employees who file confidential financial disclosures and expires after 5 years. Agencies must also submit annual reports to Congress on how many employees filed such disclosures and the number of royalty-related conflicts identified.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2024
Committee Review
Floor Vote
President
Introduced Apr 2, 2024
Last action Apr 2, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 2, 2024
Committee
Referred to the Committee on Oversight and Accountability, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 2, 2024
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7853
Scope: US
Hi! I can help you understand HR 7853. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline